- Home
- CTNT vs TCRT Comparison
CTNT vs TCRT Comparison
Compare CTNT & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTNT | TCRT |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 4.9M |
| IPO Year | 2023 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CTNT | TCRT |
|---|---|---|
| Price | $1.59 | $1.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 331.8K | 8.9K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.74 | 24.66 |
| EPS | ★ N/A | N/A |
| Revenue | $1,288,536.00 | ★ $15,900,000.00 |
| Revenue This Year | $42.49 | N/A |
| Revenue Next Year | $22.22 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 182.69 | N/A |
| 52 Week Low | $0.02 | $1.75 |
| 52 Week High | $4.21 | $4.57 |
Technical Indicators
Market Signals| Indicator | CTNT | TCRT |
|---|---|---|
| Relative Strength Index (RSI) | 43.40 | 29.15 |
| Support Level | $1.47 | N/A |
| Resistance Level | $1.70 | $2.02 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 16.32 | 9.37 |
Price Performance
Historical ComparisonAbout CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.